Skip to content

Cochlear Response Telemetry and Hearing Preservation

Association Between Intra-Operative Cochlear Response Telemetry and Hearing Preservation

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03134989
Acronym
CREST
Enrollment
80
Registered
2017-05-01
Start date
2017-12-22
Completion date
2020-06-18
Last updated
2021-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Impairment, Sensorineural

Keywords

cochlear implantation, electrocochleography

Brief summary

The main purpose of this study is to monitor the response from the cochlea as the electrode is inserted during the operation to receive a cochlear implant. The Cochlear Response Telemetry tool aims to measure the response from the cells within the cochlea and may be useful in the future to help to improve the surgical technique and potentially help surgeons better preserve any natural hearing that is available. The measurements are obtained using the cochlear implant and sound processor while a sound is presented to the ear through an earphone (like an earplug) placed into the ear canal.

Interventions

DEVICECochlear implant

Study involves measuring using Electrocochleography to measure the CM response in patients undergoing cochlear implant surgery

Sponsors

Cochlear
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Candidate for cochlear implantation (with CI522, CI532, CI622, CI632 or Hybrid-L24 (US only) according to local indications * 18 years of age or older at the time of enrolment * Pre-operative audiometric threshold in the implanted ear at 500 Hz of better than or equal to 80 dB HL * Willingness to participate in and to comply with all requirements of the protocol

Exclusion criteria

* Prior cochlear implantation in the ear to be implanted * Ossification or any other cochlear anomaly that might prevent complete insertion of the electrode array * Abnormal cochlear/nerve anatomy on pre-operative CT or MRI imaging (excluding a mild Mondini malformation or Large Vestibular Aqueduct Syndrome) * Deafness due to lesions of the acoustic nerve or central auditory pathway * Diagnosis of auditory neuropathy * Active middle-ear infection * Additional handicaps that would prevent participation in evaluations * Unrealistic expectations on the part of the subject, regarding the possible benefits, risks and limitations that are inherent to the procedure and investigational device

Design outcomes

Primary

MeasureTime frameDescription
Change in Low-frequency Hearing Thresholds Assessed Audiometrically Pre- and Post-operatively.Baseline measurement (pre-operatively) compared to 4 to 6 weeks post-surgeryAverage low-frequency (LF) hearing thresholds (average thresholds at 500, 750, and 1000 Hz) will be measured for the implanted ear 4 to 6 weeks following surgery and compared with average LF hearing thresholds measured relative to the pre-operative baseline measured within 90 days of CI surgery. The outcome measure of interest is the change in average LF hearing thresholds pre- to postoperative for each subject. The average change observed for individual subjects will then be compared with individual electrophysiological cochlear microphonic (CM) measures made during the surgery using the Cochlear Response Telemetry System. Of specific interest is whether or not compromised CM measures relate to pre-to-postoperative changes in low-frequency hearing. In other words, are larger changes in average LF hearing thresholds observed in subjects with compromised CM measures made intraoperative versus those with uncompromised CM response?

Secondary

MeasureTime frameDescription
Change in Low-frequency Hearing Thresholds Assessed Audiometrically Pre- and Post-operatively.Baseline (pre-operative) compared to 3 months post cochlear implant activationAverage low-frequency (LF) hearing thresholds (average thresholds at 500, 750, and 1000 Hz) will be measured for the implanted ear 3 months following cochlear implant activation and compared with average LF hearing thresholds measured preoperatively. The outcome measure of interest is the change in average LF hearing thresholds pre- to postoperative for each subject. The average change observed for individual subjects will then be compared with individual electrophysiological cochlear microphonic (CM) measures made during the surgery using the Cochlear Response Telemetry System. Of specific interest is whether or not compromised CM measures relate to pre-to-postoperative changes in low-frequency hearing. In other words, are larger changes in average LF hearing thresholds observed in subjects with compromised CM measures made intraoperative versus those with uncompromised CM response.
Correlation of Preoperative High-frequency Hearing Thresholds and Cochlear Microphonic Response (Number of Electrodes Inserted When CM Detected).IntraoperativeThe onset of the cochlear microphonic (CM) response will be measured intraoperative to determine if there is a relationship between the onset of the CM response during electrode insertion and the preoperative high-frequency acoustic hearing thresholds. The onset of the CM response will be tracked by impedance measures that are interleaved with the CM recordings. As each electrode in the array enters the perilymph in the cochlea there will be a measured reduction in impedance. CM onset will be defined in terms of the nth electrode (out of the 22 electrodes) to enter the cochlea. Preoperative high-frequency hearing will be defined as the average of preoperative thresholds at frequencies of 2 kHz, 3 kHz and 4 kHz for each individual subject.

Countries

Argentina

Participant flow

Participants by arm

ArmCount
Adults Implanted With CI522, CI532, CI622, CI632 or Hybrid-L24 (US Only)
Adults (≥ 18 years of age) implanted with CI522, CI532, CI622, CI632 or Hybrid-L24 (US only) with pre-operative audiometric threshold in the ear to be implanted of better than or equal to 80 dB HL at the frequency of 500 Hz.
61
Total61

Baseline characteristics

CharacteristicAdults Implanted With CI522, CI532, CI622, CI632 or Hybrid-L24 (US Only)
AETIOLOGY
Chronic Otitis Media
1 participants
AETIOLOGY
DeaFNess Autosomal Dominant 9 (DFNA9)
1 participants
AETIOLOGY
Genetic
8 participants
AETIOLOGY
Meniere's Disease
1 participants
AETIOLOGY
Noise Exposure
4 participants
AETIOLOGY
Otosclerosis
2 participants
AETIOLOGY
Sudden Hearing Loss
2 participants
AETIOLOGY
Unknown
39 participants
AETIOLOGY
Usher's Syndrome
3 participants
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
25 Participants
Age, Categorical
Between 18 and 65 years
36 Participants
Age, Continuous59.7 Years
Age of diagnosis Severe -Profound Hearing Loss46.98 Years
Age of onset of hearing loss30.75 Years
Device
CI522/522
52 participants
Device
CI532
9 participants
EAR (Left/Right
Left Ear
31 participants
EAR (Left/Right
Right Ear
30 participants
Nature of Hearing loss
CONGENITAL WITH PROGRESSION
8 participants
Nature of Hearing loss
No Data
1 participants
Nature of Hearing loss
PROGRESSION WITH SUDDEN
1 participants
Nature of Hearing loss
PROGRESSIVE
47 participants
Nature of Hearing loss
SUDDEN
4 participants
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
35 Participants
Sex: Female, Male
Male
26 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 61
other
Total, other adverse events
15 / 61
serious
Total, serious adverse events
2 / 61

Outcome results

Primary

Change in Low-frequency Hearing Thresholds Assessed Audiometrically Pre- and Post-operatively.

Average low-frequency (LF) hearing thresholds (average thresholds at 500, 750, and 1000 Hz) will be measured for the implanted ear 4 to 6 weeks following surgery and compared with average LF hearing thresholds measured relative to the pre-operative baseline measured within 90 days of CI surgery. The outcome measure of interest is the change in average LF hearing thresholds pre- to postoperative for each subject. The average change observed for individual subjects will then be compared with individual electrophysiological cochlear microphonic (CM) measures made during the surgery using the Cochlear Response Telemetry System. Of specific interest is whether or not compromised CM measures relate to pre-to-postoperative changes in low-frequency hearing. In other words, are larger changes in average LF hearing thresholds observed in subjects with compromised CM measures made intraoperative versus those with uncompromised CM response?

Time frame: Baseline measurement (pre-operatively) compared to 4 to 6 weeks post-surgery

Population: 19 of the 80 ECochG intro-operative responses were excluded from the analysis (reasons are outlined in the CIR). A further 18 of the remaining 61 data points were excluded due to an unclear CM response resulting in N=43 responses categorized as either preserved or compromised. Further, two subjects were excluded from the primary endpoint analysis as there were no FUV1 thresholds collected. Thereby N=41.

ArmMeasureValue (MEAN)
Cochlear Implant RecipientsChange in Low-frequency Hearing Thresholds Assessed Audiometrically Pre- and Post-operatively.26.9 dB
Secondary

Change in Low-frequency Hearing Thresholds Assessed Audiometrically Pre- and Post-operatively.

Average low-frequency (LF) hearing thresholds (average thresholds at 500, 750, and 1000 Hz) will be measured for the implanted ear 3 months following cochlear implant activation and compared with average LF hearing thresholds measured preoperatively. The outcome measure of interest is the change in average LF hearing thresholds pre- to postoperative for each subject. The average change observed for individual subjects will then be compared with individual electrophysiological cochlear microphonic (CM) measures made during the surgery using the Cochlear Response Telemetry System. Of specific interest is whether or not compromised CM measures relate to pre-to-postoperative changes in low-frequency hearing. In other words, are larger changes in average LF hearing thresholds observed in subjects with compromised CM measures made intraoperative versus those with uncompromised CM response.

Time frame: Baseline (pre-operative) compared to 3 months post cochlear implant activation

Population: 5 data points were excluded from this analysis due to post-operative thresholds not being measured at FUV2 (43 - 5 = 38).

ArmMeasureValue (MEAN)
Cochlear Implant RecipientsChange in Low-frequency Hearing Thresholds Assessed Audiometrically Pre- and Post-operatively.31.52 dB
Secondary

Correlation of Preoperative High-frequency Hearing Thresholds and Cochlear Microphonic Response (Number of Electrodes Inserted When CM Detected).

The onset of the cochlear microphonic (CM) response will be measured intraoperative to determine if there is a relationship between the onset of the CM response during electrode insertion and the preoperative high-frequency acoustic hearing thresholds. The onset of the CM response will be tracked by impedance measures that are interleaved with the CM recordings. As each electrode in the array enters the perilymph in the cochlea there will be a measured reduction in impedance. CM onset will be defined in terms of the nth electrode (out of the 22 electrodes) to enter the cochlea. Preoperative high-frequency hearing will be defined as the average of preoperative thresholds at frequencies of 2 kHz, 3 kHz and 4 kHz for each individual subject.

Time frame: Intraoperative

Population: 40 data points with a CM response were eligible to be analysed for this outcome. Those excluded were due to an absence of CM under visual inspection (n =16), an absence of the impedance measurement used to calculate depth (n = 4), or an array that was withdrawn or reinserted at any time (n = 5).

ArmMeasureValue (NUMBER)
Cochlear Implant RecipientsCorrelation of Preoperative High-frequency Hearing Thresholds and Cochlear Microphonic Response (Number of Electrodes Inserted When CM Detected).0.78 Pearson correlation coefficient

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026